Key Insights

Highlights

Treatment Research

5 treatments under study, led by Adolonta 100 Mgml Solución Oral

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Unknown1

Clinical Trials (1)

Research Network

Common Treatments

  • Adolonta 100 Mgml Solución Oral1
  • Pl 1granules For Oral Solution1
  • Ibuprofen Argininetramadol Hcl 400375 Mg Granules For Oral Solution1
  • Ibuprofen Arginine1
  • Pl 2oral Solution1

Active Sponsors

  • Farmalider S.A.1

Activity Timeline